Immuno-Oncology 2.0 Roundtable: Emerging Players Eye Crowded Field
Executive Summary
Scrip spoke with five companies about their places in the crowded IO field in which big pharma and small biotech firms alike are seeking the best options for harnessing the immune system to fight cancer.